Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China flag China · Delayed Price · Currency is CNY
15.94
-0.62 (-3.74%)
Nov 13, 2026, 3:00 PM CST

Shanghai ZJ Bio-Tech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-63.11-34.3-127.46-136.86760.27758.52
Depreciation & Amortization
64.8665.2768.466.6960.2424.84
Other Amortization
2.241.830.720.590.08-
Loss (Gain) From Sale of Assets
-0.04-0.04-0.04--0.03-
Asset Writedown & Restructuring Costs
0.430.4322.531.150.590.03
Loss (Gain) From Sale of Investments
-6.18-6.18-0.06---
Provision & Write-off of Bad Debts
9.990.398.411.366.355.38
Other Operating Activities
14.9119.25134.73169.99-62.7628.33
Change in Accounts Receivable
27.8827.8837.31114.7712.17-25.19
Change in Inventory
10.5110.5136.3731.72-297.19-172.51
Change in Accounts Payable
-10.98-10.98-81.05-304.21104.4916.72
Change in Other Net Operating Assets
0.730.730.980.611.185.86
Operating Cash Flow
43.366.8577.59-81.88584.97641.94
Operating Cash Flow Growth
-35.70%-13.84%---8.87%-43.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-23.36-1.99-19.49-81.15-74.56-498.06
Sale of Property, Plant & Equipment
0.290.630.011.140.06-
Investment in Securities
-98.77-305.360.062.32-1.53-21
Investing Cash Flow
-121.84-306.72-19.42-77.69-76.02-519.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-297----
Long-Term Debt Repaid
--5.22-2.51-3.65-3.75-
Lease Payments
-2.24-2.24-2.51-3.65-3.75-
Net Debt Issued (Repaid)
89.82291.78-2.51-3.65-3.75-
Issuance of Common Stock
-----1,959
Repurchase of Common Stock
-259.11-259.11-35.33--102.03-
Common Dividends Paid
-6.32-3.03-20.88-230.74-265.62-311.53
Other Financing Activities
153.47-----19.3
Financing Cash Flow
-22.1429.64-58.72-234.39-371.41,628

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-54.04-23.0114.4415.7774.35-19.82
Net Cash Flow
-154.72-233.2413.89-378.19211.91,731

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
19.9464.8658.1-163.03510.41143.88
Free Cash Flow Growth
-70.48%11.63%--254.76%-86.52%
Free Cash Flow Margin
16.81%51.96%32.52%-59.43%21.94%7.13%
Free Cash Flow Per Share
0.120.360.30-0.852.640.76
Levered Free Cash Flow
3.7143.1542.13-98.85410.82-144.71
Unlevered Free Cash Flow
4.5945.3342.35-98.63411.11-144.71
Free Cash Flow After Leases
17.762.6255.6-166.68506.66143.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--12.1817.2152.97188.93261.3
Change in Working Capital
20.2120.21-29.64-184.81-179.76-175.17